New DARZALEX® (Daratumumab) Combination Expands Options for Use in Newly Diagnosed, Transplant Ineligible Multiple Myeloma Patients
Combination therapy has become a common way to treat many cancers, as the complexity presented by certain types requires a variety of therapies to attack it.